ハイスループットスクリーニング（HTS）市場 – 2029年までの世界予測

Report Overview

The global high-throughput screening market size is projected to reach USD 50.2 billion by 2029 from USD 28.8 billion in 2024, at a CAGR of 11.8% during the forecast period.

世界のハイスループットスクリーニング（HTS）市場規模は、予測期間中のCAGR 11.8%で、2024年の288億米ドルから2029年までに502億米ドルに達すると予測されています。

Pharmaceutical & biotechnology companies collaborate with academic institutions, research organizations, and technology providers, enabling them to access external expertise and novel technologies in high-throughput screening (HTS). For instance, in 2023, ChemDiv, Inc. (US) collaborated with the University of Texas Medical Branch (UTMB) to expand its inventory and advance its high throughput screening (HTS) research programs. Furthermore, institutions such as the University of Florida Health (US) collaborate with research groups for various high-throughput screening applications, including assay development, pilot screening, and HTS campaigns. The university’s High Throughput Molecular Screening Center supports researchers by providing grant support for their research  Similarly, major pharmaceutical companies, such as Novartis AG (Switzerland), invested USD 3.64 billion in 2023, for exploratory research to discover and develop new drug candidates. This investment was 24% higher than the previous year’s investment. With the increased allocation of resources to research and development by pharmaceutical companies and research institutions, there will be a growing demand for efficient and effective drug discovery technologies like high throughput screening (HTS).

“The services segment is set to register highest growth rate during 2024-2029 in the high throughput screening (HTS) market”

The high-throughput screening (HTS) offerings market is segmented into consumables, instruments, services, and software. Services in the high-throughput screening (HTS) market include high-throughput screening services, assay development services, cell line development services, and microplate development services. These services are essential for high-throughput screening as they offer tools and processes necessary for effective drug discovery and life science research. Factors such as increasing assay complexities for drug development and hit identification, along with the growing demand for cost-effective and specialized high-throughput screening (HTS) expertise drive the growth of the service segment. Service providers also help mitigate research and regulatory risks and allow pharmaceutical and biotechnology companies to focus on their core competencies. Owing to these factors, the high-throughput screening (HTS) services segment has emerged as a beneficial market space for companies and registered the highest growth rate in the market during the forecast period.

“CRO end user segment is set to witness the highest growth rate in the HTS market”

Based on end user, the high-throughput screening market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations (CROs), and other end users. Contract Research Organizations (CROs) are projected to witness the highest growth rate during the forecast period. This growth can be attributed to factors such as the growing trend of outsourcing of R&D activities by pharmaceutical and biotechnology companies to research organizations such as CROs. High throughput screening (HTS) allows CROs to rapidly screen large libraries of compounds against specific targets, making lead discovery more efficient. By identifying unsuitable compounds early, CROs can reduce costs and risks for their pharmaceutical clients, saving time and money and minimizing the risk of late-stage failures. CROs are investing in advanced HTS technologies and infrastructure, allowing them to perform complex screens not feasible for smaller companies. For instance, Labcorp Drug Development services use robotic screening systems, and Parexel integrates AI and machine learning with HTS to enhance their screening capabilities

“Drug Discovery segment accounted for the highest CAGR”

Based on application, the high-throughput screening (HTS) market is segmented into drug discovery, biochemical screening, life sciences research, and other applications. The drug discovery segment is projected to grow with the highest CAGR throughout 2024 to 2029. The key factor driving this segment’s growth is the increasing prevalence of diseases leading to a rise in pharmaceutical drug discovery research and development. Pharmaceutical companies are utilizing this technology for lead discovery, target validation, primary screening, compound profiling, and hit identification  Additionally, ongoing advancements such as automation and AI integration, in high-throughput screening (HTS) technologies further aid in making the drug discovery process more efficient and cost-effective supporting the growth of the market.

“Asia Pacific: The fastest-growing country in the high-throughput screening market”

The high-throughput screening (HTS) market is segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Asia Pacific is projected to register the highest CAGR during the forecast period. Factors such as rising pharmaceutical R&D spending, growing public-private partnerships, and increasing government funding drive the growth of the HTS market in this region.

The primary interviews conducted for this report can be categorized as follows:

• By Respondent: Supply Side -80% and Demand Side – 20%
• By Designation: Managers -45%, CXOs and Directors -30%, and Executives – 25%
• By Region: North America-55%, Europe -15%, Asia-Pacific -15%, Latin America-10%, Middle East and Africa-5%

Lists of Companies Profiled in the Report:

• Thermo Fisher Scientific Inc. (US)
• Agilent Technologies, Inc. (US)
• Merck KGaA (Germany)
• Danaher Corporation (US)
• Revvity, Inc. (US)
• Tecan Group Ltd. (Switzerland)
• Bio-Rad Laboratories, Inc. (US)
• Corning Incorporated (US)
• Mettler-Toledo International Inc. (US)
• Lonza Group (Switzerland)
• Waters Corporation (US)
• Sartorius AG (Germany)
• Eppendorf SE (Germany)
• Porvair Plc (UK)
• Greiner AG (Austria)
• Charles River Laboratories (US)
• Eurofins Scientific (Luxembourg)
• Hamilton Company (US)
• Aurora Biomed Inc. (Canada)
• Gilson Incorporated (US)
• Brand GmbH+Co KG (Germany)
• BMG Labtech GmbH (Germany)
• DIANA Biotechnologies (Czechia)
• A.S. (Czech Republic)
• Creative Biolabs (US)
• HighRes Biosolutions (US)
• Biomat Srl, (Italy)
• Axxam S.p.A. (Italy)
• Sygnature Discovery Limited (UK)
• Crown Bioscience (US)

Research Coverage:

This report provides a detailed picture of the high throughput screening market. It aims at estimating the size and future growth potential of the market across different segments, such as offerings, technology, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Reasons to Buy the Report:

The report provides insights on the following pointers:

• Analysis of key drivers (the growing adoption of open innovative models in pharmaceutical & biotechnology companies, rising government funding and venture capital investments, increasing R&D spending, and technological advancements), restraints (high costs of using HTS instruments), opportunities (increasing adoption of HTS technologies in emerging markets, growing research on novel therapeutics and application of HTS technology in drug repurposing), and challenges (lack of skilled operators, and complexities in data management, assay development, and analysis) influencing the growth of the high throughput screening (HTS) market.

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the high throughput screening (HTS) market.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various high-throughput screening opportunities and developments across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the high-throughput screening (HTS) market.

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players like Thermo Fisher Scientific Inc. (US), Agilent Technologies, Inc. (US), Merck KGaA (Germany), Danaher Corporation (US), Revvity, Inc. (US), among others in the high-throughput screening market.

Table of Contents

1            INTRODUCTION            46

1.1         STUDY OBJECTIVES      46

1.2         MARKET DEFINITION   46

1.2.1      INCLUSIONS & EXCLUSIONS     47

1.3         MARKET SCOPE             48

1.3.1      SEGMENTS COVERED   48

1.3.2      REGIONS COVERED      49

1.3.3      YEARS CONSIDERED     49

1.4         CURRENCY CONSIDERED          50

1.5         LIMITATIONS   50

1.6         STAKEHOLDERS            50

1.7         SUMMARY OF CHANGES            51

1.7.1      RECESSION IMPACT      52

2            RESEARCH METHODOLOGY     53

2.1         RESEARCH DATA           53

2.1.1      SECONDARY DATA       54

2.1.2      PRIMARY DATA 54

2.2         MARKET SIZE ESTIMATION       55

2.2.1      INSIGHTS FROM PRIMARIES      58

2.3         MARKET GROWTH FORECAST  59

2.4         MARKET BREAKDOWN & DATA TRIANGULATION          61

2.5         RESEARCH ASSUMPTIONS         62

2.6         RISK ANALYSIS 62

2.7         RECESSION IMPACT ON HIGH-THROUGHPUT SCREENING (HTS) MARKET            62

3            EXECUTIVE SUMMARY 64

4            PREMIUM INSIGHTS      68

4.1         HIGH-THROUGHPUT SCREENING (HTS) MARKET OVERVIEW   68

4.2         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE,

BY OFFERING AND COUNTRY (2023)     69

4.3         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2024 VS. 2029 (USD MILLION)   70

4.4         HIGH-THROUGHPUT SCREENING (HTS) MARKET SHARE, BY END USER, 2023         70

4.5         HIGH-THROUGHPUT SCREENING (HTS) MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES       71

5            MARKET OVERVIEW     72

5.1         INTRODUCTION            72

5.2         MARKET DYNAMICS     72

5.2.1      DRIVERS            73

5.2.1.1   Growing adoption of open innovation models 73

5.2.1.2   Rising government funding and venture capital investments      74

5.2.1.3   Increasing R&D spending  76

5.2.1.4   Technological advancements           77

5.2.2      RESTRAINTS     78

5.2.2.1   High cost of using HTS instruments 78

5.2.3      OPPORTUNITIES           79

5.2.3.1   Increasing adoption of HTS technologies in emerging markets  79

5.2.3.2   Growing research on novel therapeutics         79

5.2.3.3   Drug repurposing 80

5.2.4      CHALLENGES   81

5.2.4.1   Lack of skilled operators    81

5.2.4.2   Complexities in data management, assay development, and analysis        81

5.3         INDUSTRY TRENDS       82

5.3.1      ADOPTION OF PHENOTYPIC SCREENING          82

5.3.2      AUTOMATION AND AI INTEGRATION  82

5.3.3      RISE OF CRISPR TECHNOLOGY 82

5.3.4      INTEGRATION OF SINGLE-CELL ANALYSIS TECHNOLOGIES      82

5.3.5      REGULATORY CONSIDERATIONS          83

5.4         TECHNOLOGY ANALYSIS           83

5.4.1      KEY TECHNOLOGIES    83

5.4.1.1   High-content screening/analysis     83

5.4.1.2   Label-free detection (surface plasmon resonance)       83

5.4.2      COMPLEMENTARY TECHNOLOGIES     84

5.4.2.1   Microfluidics, organ-on-a-chip (OOC), and lab-on-a-chip (LOC)           84

5.4.2.2   Mass spectrometry (MS)   84

5.4.2.3   Flow cytometry    85

5.4.3      ADJACENT TECHNOLOGIES      85

5.4.3.1   Fragment-based drug discovery       85

5.5         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 86

5.6         PRICING ANALYSIS        86

5.7         VALUE CHAIN ANALYSIS            89

5.8         SUPPLY CHAIN ANALYSIS          90

5.9         ECOSYSTEM ANALYSIS 91

5.9.1      HIGH-THROUGHPUT SCREENING MARKET:

ROLE OF RAW MATERIAL VENDORS      92

5.9.2      HIGH-THROUGHPUT SCREENING MARKET: ROLE OF PRODUCT &

SERVICE PROVIDERS   92

5.9.3      HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS              93

5.9.4      HIGH-THROUGHPUT SCREENING MARKET:

ROLE OF REGULATORY AUTHORITIES 94

5.10       PATENT ANALYSIS        94

5.11       TRADE ANALYSIS          97

5.11.1    IMPORT DATA FOR SPECTROMETERS  97

5.11.2    IMPORT DATA FOR MASS SPECTROMETERS      99

5.11.3    EXPORT DATA FOR SPECTROMETERS  101

5.11.4    EXPORT DATA FOR MASS SPECTROMETERS      103

5.12       REGULATORY ANALYSIS            104

5.12.1    REGULATORY LANDSCAPE       104

5.12.1.1 US         105

5.12.1.2 Europe  105

5.12.1.3 Emerging markets              105

5.12.2    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          106

5.13       PORTER’S FIVE FORCES ANALYSIS         109

5.13.1    INTENSITY OF COMPETITIVE RIVALRY 110

5.13.2    BARGAINING POWER OF SUPPLIERS     111

5.13.3    BARGAINING POWER OF BUYERS           111

5.13.4    THREAT OF SUBSTITUTES         111

5.13.5    THREAT OF NEW ENTRANTS    111

5.14       KEY CONFERENCES & EVENTS, 2024–2025           112

5.15       KEY STAKEHOLDERS & BUYING CRITERIA          113

5.15.1    KEY STAKEHOLDERS IN BUYING PROCESS OF HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES      113

5.15.2    BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES       114

5.15.3    BUYING CRITERIA FOR HIGH-THROUGHPUT SCREENING PRODUCTS & SERVICES, BY END USER         114

6            HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING              117

6.1         INTRODUCTION            118

6.2         CONSUMABLES 118

6.2.1      REAGENTS & ASSAY KITS           122

6.2.1.1   Growing applications of HTS in drug discovery and life science research to support demand for consumables   122

6.2.2      LABORATORY CONSUMABLES  126

6.2.2.1   Growing automation in high-throughput screening to

propel market growth         126

6.3         INSTRUMENTS 129

6.3.1      LIQUID HANDLING SYSTEMS    133

6.3.1.1   Ongoing technological advancements and automation to support market growth              133

6.3.2      DETECTION SYSTEMS  137

6.3.2.1   High demand for high-throughput and sensitive detection systems to propel market   137

6.3.3      IMAGING INSTRUMENTS           141

6.3.3.1   Advancements in high-content imaging systems to boost market             141

6.3.4      OTHER INSTRUMENTS 145

6.4         SERVICES          148

6.4.1      INCREASING ASSAY COMPLEXITIES AND GROWING NEED FOR COST-EFFECTIVE AND SPECIALIZED HTS EXPERTISE TO BOOST DEMAND     148

6.5         SOFTWARE       151

6.5.1      ONGOING INTEGRATION OF ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING SOFTWARE TOOLS TO DRIVE MARKET    151

7            HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION              155

7.1         INTRODUCTION            156

7.2         DRUG DISCOVERY         156

7.2.1      GROWING DEMAND FOR MORE EFFECTIVE METHODS TO IDENTIFY NEW DRUG CANDIDATES TO SUPPORT MARKET GROWTH       156

7.3         BIOCHEMICAL SCREENING       160

7.3.1      GROWING AWARENESS OF GENETIC DISORDERS AND SCREENING TESTS TO BOOST MARKET GROWTH    160

7.4         LIFE SCIENCE RESEARCH           164

7.4.1      INCREASING INVESTMENTS IN STEM CELL RESEARCH TO CONTRIBUTE TO MARKET GROWTH    164

7.5         OTHER APPLICATIONS 168

8            HIGH-THROUGHPUT SCREENING MARKET, BY TECHNOLOGY 172

8.1         INTRODUCTION            173

8.2         CELL-BASED ASSAYS     173

8.2.1      2D CELL CULTURES      178

8.2.1.1   Cost-effectiveness of 2D cell cultures to promote market growth             178

8.2.2      3D CELL CULTURES      181

8.2.2.1   Scaffold-based technology 185

8.2.2.1.1 Hydrogels            189

8.2.2.1.1.1           Animal-derived hydrogels  193

8.2.2.1.1.1.1        Matrigel 196

8.2.2.1.1.1.1.1      Increasing applications of Matrigel in drug discovery and life science research to support market growth   196

8.2.2.1.1.1.2        Collagen 200

8.2.2.1.1.1.2.1      Growing demand for personalized medicines to support market growth              200

8.2.2.1.1.2           Synthetic hydrogels           203

8.2.2.1.1.2.1        Better consistency and low risk of contamination to increase adoption and drive growth  203

8.2.2.1.1.3           Alginate/Agarose 207

8.2.2.1.1.3.1        Ability of alginate to enhance accuracy and relevance to propel adoption              207

8.2.2.1.2 Inert matrices/Solid scaffolds          210

8.2.2.1.2.1           Lack of native-like microenvironment and other disadvantages to restrain growth   210

8.2.2.1.3 Micropatterned surfaces    214

8.2.2.1.3.1           Greater enzyme levels and drug reactivity to support adoption   214

8.2.2.2   Scaffold-free technology    217

8.2.2.2.1 Ultra-low-binding plates    221

8.2.2.2.1.1           Demand for high-quality, low-background assays to boost market              221

8.2.2.2.2 Hanging-drop plates          224

8.2.2.2.2.1           Cost-effectiveness to boost adoption among end users 224

8.2.2.2.3 Other scaffold-free technologies      228

8.2.3      REPORTER-BASED ASSAYS        232

8.2.3.1   Growing applications of gene expression to support growth       232

8.2.4      PERFUSION CELL CULTURES    235

8.2.4.1   Ongoing research to develop perfusion cell culture technology for drug discovery to support adoption           235

8.3         LAB-ON-A-CHIP             239

8.3.1      INCREASING APPLICATIONS OF LAB-ON-A-CHIP TECHNOLOGY FOR HTS AND PRECISION MEDICINE DEVELOPMENT TO SUPPORT MARKET GROWTH          239

8.4         LABEL-FREE TECHNOLOGY      242

8.4.1      ABILITY TO CONDUCT LABEL-FREE INVESTIGATION OF BIOMOLECULAR INTERACTIONS TO PROPEL ADOPTION          242

9            HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER              246

9.1         INTRODUCTION            247

9.2         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES   247

9.2.1      GROWING DEMAND FOR HTS SOLUTIONS IN LEAD DISCOVERY TO SUPPORT MARKET GROWTH    247

9.3         ACADEMIC & RESEARCH INSTITUTES   251

9.3.1      GROWING ADOPTION OF HTS IN COLLABORATIVE ACADEMIC & RESEARCH ACTIVITIES TO AID MARKET GROWTH        251

9.4         CONTRACT RESEARCH ORGANIZATIONS (CROS)           255

9.4.1      INCREASING OUTSOURCING OF R&D ACTIVITIES TO DRIVE MARKET GROWTH FOR CROS      255

9.5         OTHER END USERS        259

10          HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION  262

10.1       INTRODUCTION            263

10.2       NORTH AMERICA          263

10.2.1    NORTH AMERICA: RECESSION IMPACT 264

10.2.2    US         270

10.2.2.1 Presence of major research institutes and key pharmaceutical companies to support market growth       270

10.2.3    CANADA            275

10.2.3.1 Government initiatives promoting research to support market growth     275

10.3       EUROPE             280

10.3.1    EUROPE: RECESSION IMPACT   280

10.3.2    GERMANY         285

10.3.2.1 Increasing research initiatives to boost market growth 285

10.3.3    UK         290

10.3.3.1 Investments by pharmaceutical sponsors for drug discovery to support market              290

10.3.4    FRANCE             295

10.3.4.1 Large pharmaceutical R&D expenditure to drive market growth 295

10.3.5    ITALY   300

10.3.5.1 Strong collaborative research networks to fuel growth  300

10.3.6    SPAIN   305

10.3.6.1 Rising R&D expenditure and increasing public-private partnerships to boost market   305

10.3.7    REST OF EUROPE           310

10.4       ASIA PACIFIC    315

10.4.1    ASIA PACIFIC: RECESSION IMPACT        316

10.4.2    CHINA  322

10.4.2.1 Growing research and collaborations in field of drug discovery to support growth of market             322

10.4.3    JAPAN  327

10.4.3.1 Growing focus on research and strategic collaborations to support market growth              327

10.4.4    INDIA   332

10.4.4.1 Developing healthcare industry and ongoing government initiatives to create favorable opportunities for market players     332

10.4.5    AUSTRALIA       337

10.4.5.1 Growing pharmaceutical industry to create favorable opportunities for market players   337

10.4.6    SOUTH KOREA 342

10.4.6.1 Growing pharmaceutical industry to favor market growth          342

10.4.7    REST OF ASIA PACIFIC (ROAPAC)           347

10.5       LATIN AMERICA             351

10.5.1    LATIN AMERICA: RECESSION IMPACT   352

10.5.2    BRAZIL 357

10.5.2.1 Gradual growth in research to contribute to growth     357

10.5.3    MEXICO             362

10.5.3.1 Favorable government support to contribute to growth 362

10.5.4    REST OF LATIN AMERICA          366

10.6       MIDDLE EAST  371

10.6.1    MIDDLE EAST: RECESSION IMPACT       371

10.6.2    GCC COUNTRIES           376

10.6.2.1 Saudi Arabia        381

10.6.2.1.1            Growing pharmaceuticals industry to support market growth     381

10.6.2.2 UAE      386

10.6.2.2.1            High R&D expenditure and advanced healthcare infrastructure to boost market growth     386

10.6.2.3 Rest of GCC Countries      390

10.7       AFRICA 399

10.7.1    INCREASING FUNDING AND PARTNERSHIPS IN RESEARCH SECTOR TO AID MARKET GROWTH 399

10.7.2    AFRICA: RECESSION IMPACT     399

11          COMPETITIVE LANDSCAPE       404

11.1       OVERVIEW        404

11.2       KEY PLAYER STRATEGY/RIGHT TO WIN             404

11.2.1    OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HIGH-THROUGHPUT SCREENING (HTS) MARKET       405

11.3       REVENUE ANALYSIS      406

11.4       MARKET SHARE ANALYSIS         407

11.5       COMPANY EVALUATION QUADRANT: KEY PLAYERS, 2023          409

11.5.1    STARS  410

11.5.2    EMERGING LEADERS    410

11.5.3    PERVASIVE PLAYERS     410

11.5.4    PARTICIPANTS 410

11.5.5    COMPANY FOOTPRINT: KEY PLAYERS, 2023      412

11.5.5.1 Company footprint            412

11.5.5.2 Offering footprint 413

11.5.5.3 Application footprint         414

11.5.5.4 Region footprint  415

11.6       COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023          416

11.6.1    PROGRESSIVE COMPANIES       416

11.6.2    RESPONSIVE COMPANIES          416

11.6.3    DYNAMIC COMPANIES 416

11.6.4    STARTING BLOCKS       416

11.6.5    COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023             418

11.7       COMPANY VALUATION & FINANCIAL METRICS 420

11.7.1    FINANCIAL METRICS    420

11.7.2    COMPANY VALUATION 420

11.8       BRAND/PRODUCT COMPARISON          421

11.9       COMPETITIVE SCENARIO          422

11.9.1    PRODUCT LAUNCHES  422

11.9.2    DEALS  424

11.9.3    EXPANSIONS    426

12          COMPANY PROFILES    427

12.1       KEY PLAYERS   427

12.1.1    THERMO FISHER SCIENTIFIC INC.          427

12.1.1.1 Business overview 427

12.1.1.2 Products & services offered             428

12.1.1.3 Recent developments         432

12.1.1.3.1            Product launches & approvals          432

12.1.1.3.2            Deals     432

12.1.1.3.3            Expansions          433

12.1.1.4 MnM view           434

12.1.1.4.1            Right to win         434

12.1.1.4.2            Strategic choices  434

12.1.1.4.3            Weaknesses & competitive threats   434

12.1.2    AGILENT TECHNOLOGIES, INC.             435

12.1.2.1 Business overview 435

12.1.2.2 Products & services offered             436

12.1.2.3 Recent developments         440

12.1.2.3.1            Product launches & upgrades           440

12.1.2.3.2            Deals     441

12.1.2.4 MnM view           442

12.1.2.4.1            Right to win         442

12.1.2.4.2            Strategic choices  442

12.1.2.4.3            Weaknesses & competitive threats   442

12.1.3    MERCK KGAA   443

12.1.3.1 Business overview 443

12.1.3.2 Products & services offered             444

12.1.3.3 Recent developments         446

12.1.3.3.1            Other developments          446

12.1.3.4 MnM view           446

12.1.3.4.1            Right to win         446

12.1.3.4.2            Strategic choices  446

12.1.3.4.3            Weaknesses & competitive threats   446

12.1.4    DANAHER CORPORATION         447

12.1.4.1 Business overview 447

12.1.4.2 Products & services offered             448

12.1.4.3 Recent developments         452

12.1.4.3.1            Product & service launches 452

12.1.4.3.2            Deals     453

12.1.4.3.3            Expansions          454

12.1.5    REVVITY, INC.   455

12.1.5.1 Business overview 455

12.1.5.2 Products & services offered             456

12.1.5.3 Recent developments         459

12.1.5.3.1            Product launches 459

12.1.5.3.2            Deals     459

12.1.6    TECAN GROUP LTD.     460

12.1.6.1 Business overview 460

12.1.6.2 Products & service offered 461

12.1.6.3 Recent developments         463

12.1.6.3.1            Product launches & upgrades           463

12.1.6.3.2            Deals     463

12.1.7    BIO-RAD LABORATORIES, INC. 464

12.1.7.1 Business overview 464

12.1.7.2 Products & services offered             465

12.1.7.3 Recent developments         468

12.1.7.3.1            Product launches 468

12.1.8    CORNING INCORPORATED       469

12.1.8.1 Business overview 469

12.1.8.2 Products & services offered             470

12.1.8.3 Recent developments         472

12.1.8.3.1            Product launches 472

12.1.9    METTLER-TOLEDO INTERNATIONAL INC.         473

12.1.9.1 Business overview 473

12.1.9.2 Products & services offered             474

12.1.9.3 Recent developments         476

12.1.9.3.1            Product launches 476

12.1.10  LONZA GROUP 477

12.1.10.1             Business overview 477

12.1.10.2             Products & services offered             478

12.1.10.3             Recent developments         479

12.1.10.3.1          Deals     479

12.1.11  WATERS CORPORATION            480

12.1.11.1             Business overview 480

12.1.11.2             Products & services offered             481

12.1.11.3             Recent developments         483

12.1.11.3.1          Product launches 483

12.1.11.3.2          Deals     484

12.1.12  SARTORIUS AG 485

12.1.12.1             Business overview 485

12.1.12.2             Products & services offered             486

12.1.12.3             Recent developments         491

12.1.12.3.1          Product launches 491

12.1.13  EPPENDORF SE 492

12.1.13.1             Business overview 492

12.1.13.2             Products & services offered             493

12.1.13.3             Recent developments         495

12.1.13.3.1          Deals     495

12.1.13.3.2          Expansions          495

12.1.14  PORVAIR PLC   496

12.1.14.1             Business overview 496

12.1.14.2             Products & services offered             497

12.1.15  GREINER AG     499

12.1.15.1             Business overview 499

12.1.15.2             Products & services offered             500

12.1.16  CHARLES RIVER LABORATORIES            503

12.1.16.1             Business overview 503

12.1.16.2             products & services offered 504

12.1.16.3             Recent developments         505

12.1.16.3.1          Deals     505

12.1.17  EUROFINS SCIENTIFIC  506

12.1.17.1             Business overview 506

12.1.17.2             Products & services offered             507

12.1.17.3             Recent developments         509

12.1.17.3.1          Service launches  509

12.1.17.3.2          Deals     509

12.1.17.3.3          Expansions          510

12.1.18  HAMILTON COMPANY 511

12.1.18.1             Business overview 511

12.1.18.2             Products & services offered             511

12.1.18.3             Recent developments         512

12.1.18.3.1          Product launches 512

12.1.18.3.2          Deals     513

12.1.19  AURORA BIOMED INC.  514

12.1.19.1             Business overview 514

12.1.19.2             Products & services offered             514

12.1.20  GILSON INCORPORATED           515

12.1.20.1             Business overview 515

12.1.20.2             Products & services offered             515

12.1.20.3             Recent developments         521

12.1.20.3.1          Product launches 521

12.1.20.3.2          Deals     522

12.1.21  BRAND GMBH + CO KG 523

12.1.21.1             Business overview 523

12.1.21.2             Products & services offered             524

12.1.21.3             Recent developments         527

12.1.21.3.1          Expansions          527

12.2       OTHER PLAYERS           528

12.2.1    BMG LABTECH GMBH  528

12.2.2    DIANA BIOTECHNOLOGIES, A.S.            529

12.2.3    CREATIVE BIOLABS       530

12.2.4    HIGHRES BIOSOLUTIONS          532

12.2.5    BIOMAT SRL     533

12.2.6    AXXAM S.P.A.    534

12.2.7    SYGNATURE DISCOVERY LIMITED        535

12.2.8    CROWN BIOSCIENCE    537

13          APPENDIX         538

13.1       DISCUSSION GUIDE      538

13.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             543

13.3       CUSTOMIZATION OPTIONS      545

13.4       RELATED REPORTS       545

13.5       AUTHOR DETAILS         546

LIST OF TABLES

TABLE 1             GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)         63

TABLE 2             HIGH-THROUGHPUT SCREENING MARKET: IMPACT ANALYSIS              73

TABLE 3             AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS, 2023   87

TABLE 4             AVERAGE SELLING PRICE FOR HIGH-THROUGHPUT SCREENING PRODUCTS,

BY REGION        87

TABLE 5             INDICATIVE PRICING FOR HIGH-THROUGHPUT SCREENING PRODUCTS, BY REGION, 2021–2023 (USD)           88

TABLE 6             HIGH-THROUGHPUT SCREENING MARKET: ROLE OF RAW MATERIAL VENDORS    92

TABLE 7             HIGH-THROUGHPUT SCREENING MARKET: ROLE OF

PRODUCT & SERVICE PROVIDERS         92

TABLE 8             HIGH-THROUGHPUT SCREENING MARKET: ROLE OF END USERS  93

TABLE 9             HIGH-THROUGHPUT SCREENING MARKET: ROLE OF REGULATORY AUTHORITIES    94

TABLE 10           PATENTS FILED, BY DOCUMENT TYPE, 2012–2023          94

TABLE 11           INDICATIVE LIST OF PATENTS IN HIGH-THROUGHPUT SCREENING MARKET    96

TABLE 12           IMPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)        97

TABLE 13           IMPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)         98

TABLE 14           IMPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY,

2022–2023 (USD THOUSAND)     99

TABLE 15           IMPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY,

2022–2023 (UNITS)         100

TABLE 16           EXPORT DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (USD THOUSAND)        101

TABLE 17           EXPORT VOLUME DATA FOR SPECTROMETERS, BY COUNTRY, 2019–2023 (UNITS)         102

TABLE 18           EXPORT DATA FOR MASS SPECTROMETERS, BY COUNTRY,

2019–2023 (USD THOUSAND)     103

TABLE 19           EXPORT VOLUME DATA FOR MASS SPECTROMETERS, BY COUNTRY,

2019–2023 (UNITS)         104

TABLE 20           NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 106

TABLE 21           EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 107

TABLE 22           ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 108

TABLE 23           LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 108

TABLE 24           MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         109

TABLE 25           HIGH-THROUGHPUT SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS         109

TABLE 26           HIGH-THROUGHPUT SCREENING MARKET: LIST OF CONFERENCES & EVENTS          112

TABLE 28           HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)            119

TABLE 29           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)        119

TABLE 30           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            120

TABLE 31           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            120

TABLE 32           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)        121

TABLE 33           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            121

TABLE 34           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)        121

TABLE 35           HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE,

2022–2029 (USD MILLION)          122

TABLE 36           HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS,

BY REGION, 2022–2029 (USD MILLION)  123

TABLE 37           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)          123

TABLE 38           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)              124

TABLE 39           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)          124

TABLE 40           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)          125

TABLE 41           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)          125

TABLE 42           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REAGENTS & ASSAY KITS, BY COUNTRY, 2022–2029 (USD MILLION)          125

TABLE 43           HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY REGION, 2022–2029 (USD MILLION)  126

TABLE 44           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          127

TABLE 45           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)              127

TABLE 46           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          128

TABLE 47           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          128

TABLE 48           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          128

TABLE 49           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABORATORY CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION)          129

TABLE 50           HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)            130

TABLE 51           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         130

TABLE 52           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            131

TABLE 53           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            131

TABLE 54           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         132

TABLE 55           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            132

TABLE 56           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         132

TABLE 57           HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE,

2022–2029 (USD MILLION)          133

TABLE 58           HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY REGION, 2022–2029 (USD MILLION)     134

TABLE 59           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)          134

TABLE 60           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)              135

TABLE 61           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)          135

TABLE 62           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)          136

TABLE 63           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)          136

TABLE 64           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIQUID HANDLING SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)          136

TABLE 65           HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS,

BY REGION, 2022–2029 (USD MILLION) 138

TABLE 66           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)              138

TABLE 67           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)    139

TABLE 68           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)              139

TABLE 69           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)              140

TABLE 70           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)              140

TABLE 71           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DETECTION SYSTEMS, BY COUNTRY, 2022–2029 (USD MILLION)              140

TABLE 72           HIGH-THROUGHPUT SCREENING MARKET FOR FLOW CYTOMETRY INSTRUMENTS FOR DRUG DISCOVERY APPLICATIONS, BY TYPE, 2022–2029 (UNITS)         141

TABLE 73           HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS,

BY REGION, 2022–2029 (USD MILLION)  142

TABLE 74           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)          142

TABLE 75           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)              143

TABLE 76           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)          143

TABLE 77           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)          144

TABLE 78           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)          144

TABLE 79           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR IMAGING INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)          144

TABLE 80           HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS,

BY REGION, 2022–2029 (USD MILLION)  145

TABLE 81           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)              145

TABLE 82           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)   146

TABLE 83           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)              146

TABLE 84           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)              147

TABLE 85           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)              147

TABLE 86           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION)              147

TABLE 87           HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY REGION,

2022–2029 (USD MILLION)          148

TABLE 88           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            149

TABLE 89           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         149

TABLE 90           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 91           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 92           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            150

TABLE 93           GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SERVICES MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            151

TABLE 94           HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET, BY REGION,

2022–2029 (USD MILLION)          152

TABLE 95           NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            152

TABLE 96           EUROPE: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            153

TABLE 97           ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)          153

TABLE 98           LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            154

TABLE 99           MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            154

TABLE 100         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) SOFTWARE MARKET,

BY COUNTRY, 2022–2029 (USD MILLION)            154

TABLE 101         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          156

TABLE 102         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)       157

TABLE 103         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 158

TABLE 104         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          158

TABLE 105         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 159

TABLE 106         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 159

TABLE 107         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 159

TABLE 108         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR DRUG DISCOVERY APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 160

TABLE 109         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)          161

TABLE 110         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)          161

TABLE 111         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          162

TABLE 112         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     162

TABLE 113         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)          163

TABLE 114         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     163

TABLE 115         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR BIOCHEMICAL SCREENING APPLICATIONS, BY COUNTRY,

2022–2029 (USD MILLION)          163

TABLE 116         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)              165

TABLE 117         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     166

TABLE 118         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          166

TABLE 119         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     167

TABLE 120         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     167

TABLE 121         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     167

TABLE 122         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LIFE SCIENCE RESEARCH APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     168

TABLE 123         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 169

TABLE 124         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              169

TABLE 125         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)   170

TABLE 126         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              170

TABLE 127         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              171

TABLE 128         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              171

TABLE 129         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)              171

TABLE 130         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          173

TABLE 131         COMPARISON OF 2D AND 3D CELL CULTURES 173

TABLE 132         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS,

BY TYPE, 2022–2029 (USD MILLION)       174

TABLE 133         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS,

BY REGION, 2022–2029 (USD MILLION)  175

TABLE 134         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)              175

TABLE 135         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)       176

TABLE 136         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)              176

TABLE 137         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)              177

TABLE 138         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)              177

TABLE 139         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)              177

TABLE 140         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)            178

TABLE 141         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              179

TABLE 142         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)        179

TABLE 143         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              180

TABLE 144         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              180

TABLE 145         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              180

TABLE 146         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 2D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              181

TABLE 147         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   182

TABLE 148         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES,

BY REGION, 2022–2029 (USD MILLION)  182

TABLE 149         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)        182

TABLE 150         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)        183

TABLE 151         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              183

TABLE 152         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              184

TABLE 153         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              184

TABLE 154         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              184

TABLE 155         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 185

TABLE 156         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)              186

TABLE 157         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          186

TABLE 158         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 159         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          187

TABLE 160         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 161         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 162         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          188

TABLE 163         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE,

2022–2029 (USD MILLION)          189

TABLE 164         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY REGION, 2022–2029 (USD MILLION)     190

TABLE 165         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)     190

TABLE 166         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)       191

TABLE 167         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)     191

TABLE 168         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)     192

TABLE 169         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)     192

TABLE 170         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)     192

TABLE 171         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     193

TABLE 172         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY REGION, 2022–2029 (USD MILLION) 193

TABLE 173         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          194

TABLE 174         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)              194

TABLE 175         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          195

TABLE 176         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          195

TABLE 177         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          195

TABLE 178         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          196

TABLE 179         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY REGION, 2022–2029 (USD MILLION)         197

TABLE 180         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)        197

TABLE 181         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL,

BY COUNTRY, 2022–2029 (USD MILLION)            198

TABLE 182         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL,

BY COUNTRY, 2022–2029 (USD MILLION)            198

TABLE 183         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)        199

TABLE 184         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL,

BY COUNTRY, 2022–2029 (USD MILLION)          199

TABLE 185         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MATRIGEL, BY COUNTRY, 2022–2029 (USD MILLION)        199

TABLE 186         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY REGION, 2022–2029 (USD MILLION)        200

TABLE 187         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)       201

TABLE 188         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN,

BY COUNTRY, 2022–2029 (USD MILLION)            201

TABLE 189         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN,

BY COUNTRY, 2022–2029 (USD MILLION)            202

TABLE 190         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)       202

TABLE 191         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN,

BY COUNTRY, 2022–2029 (USD MILLION)            202

TABLE 192         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR COLLAGEN, BY COUNTRY, 2022–2029 (USD MILLION)       203

TABLE 193         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS,

BY REGION, 2022–2029 (USD MILLION)  204

TABLE 194         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          204

TABLE 195         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)              205

TABLE 196         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          205

TABLE 197         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          206

TABLE 198         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          206

TABLE 199         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SYNTHETIC HYDROGELS, BY COUNTRY, 2022–2029 (USD MILLION)          206

TABLE 200         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE,

BY REGION, 2022–2029 (USD MILLION)  207

TABLE 201         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)              208

TABLE 202         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)      208

TABLE 203         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)              209

TABLE 204         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)              209

TABLE 205         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)              209

TABLE 206         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ALGINATE/AGAROSE, BY COUNTRY, 2022–2029 (USD MILLION)              210

TABLE 207         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY REGION, 2022–2029 (USD MILLION)  211

TABLE 208         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION) 211

TABLE 209         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION)          212

TABLE 210         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION) 212

TABLE 211         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION) 213

TABLE 212         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION) 213

TABLE 213         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR INERT MATRICES/SOLID SCAFFOLDS, BY COUNTRY, 2022–2029 (USD MILLION) 213

TABLE 214         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY REGION, 2022–2029 (USD MILLION) 214

TABLE 215         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)          215

TABLE 216         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)              215

TABLE 217         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)          216

TABLE 218         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)          216

TABLE 219         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)          216

TABLE 220         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR MICROPATTERNED SURFACES, BY COUNTRY, 2022–2029 (USD MILLION)          217

TABLE 221         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    217

TABLE 222         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)              218

TABLE 223         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          218

TABLE 224         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)              219

TABLE 225         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          219

TABLE 226         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          220

TABLE 227         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          220

TABLE 228         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          220

TABLE 229         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY REGION, 2022–2029 (USD MILLION) 221

TABLE 230         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          222

TABLE 231         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)              222

TABLE 232         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          223

TABLE 233         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          223

TABLE 234         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          223

TABLE 235         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ULTRA-LOW-BINDING PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          224

TABLE 236         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY REGION, 2022–2029 (USD MILLION)           225

TABLE 237         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          225

TABLE 238         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)              226

TABLE 239         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          226

TABLE 240         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          227

TABLE 241         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          227

TABLE 242         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HANGING-DROP PLATES, BY COUNTRY, 2022–2029 (USD MILLION)          227

TABLE 243         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY REGION, 2022–2029 (USD MILLION)              229

TABLE 244         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)     229

TABLE 245         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)          230

TABLE 246         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)     230

TABLE 247         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)     231

TABLE 248         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)     231

TABLE 249         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER SCAFFOLD-FREE TECHNOLOGIES, BY COUNTRY, 2022–2029 (USD MILLION)     231

TABLE 250         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY REGION, 2022–2029 (USD MILLION)         232

TABLE 251         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)          233

TABLE 252         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)              233

TABLE 253         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)          234

TABLE 254         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)          234

TABLE 255         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)          234

TABLE 256         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR REPORTER-BASED ASSAYS, BY COUNTRY, 2022–2029 (USD MILLION)          235

TABLE 257         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY REGION, 2022–2029 (USD MILLION)    236

TABLE 258         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)          236

TABLE 259         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)              237

TABLE 260         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)          237

TABLE 261         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)          238

TABLE 262         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)          238

TABLE 263         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PERFUSION CELL CULTURES, BY COUNTRY, 2022–2029 (USD MILLION)          238

TABLE 264         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)         239

TABLE 265         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          240

TABLE 266         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)              240

TABLE 267         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          241

TABLE 268         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          241

TABLE 269         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          241

TABLE 270         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LAB-ON-A-CHIP TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          242

TABLE 271         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY REGION, 2022–2029 (USD MILLION)      243

TABLE 272         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          243

TABLE 273         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)              244

TABLE 274         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)              244

TABLE 275         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          245

TABLE 276         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          245

TABLE 277         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR LABEL-FREE TECHNOLOGY, BY COUNTRY, 2022–2029 (USD MILLION)          245

TABLE 278         HIGH-THROUGHPUT SCREENING MARKET (HTS), BY END USER,

2022–2029 (USD MILLION)          247

TABLE 279         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 248

TABLE 280         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)          249

TABLE 281         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)          249

TABLE 282         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)          250

TABLE 283         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)          250

TABLE 284         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)          250

TABLE 285         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY,

2022–2029 (USD MILLION)          251

TABLE 286         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION)              252

TABLE 287         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 253

TABLE 288         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)          253

TABLE 289         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 254

TABLE 290         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 254

TABLE 291         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 254

TABLE 292         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 255

TABLE 293         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2022–2029 (USD MILLION)          256

TABLE 294         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     256

TABLE 295         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)          257

TABLE 296         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     257

TABLE 297         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     258

TABLE 298         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     258

TABLE 299         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2022–2029 (USD MILLION)     258

TABLE 300         HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)        259

TABLE 301         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)              259

TABLE 302         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)         260

TABLE 303         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)              260

TABLE 304         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)              261

TABLE 305         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)              261

TABLE 306         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)              261

TABLE 307         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY REGION,

2022–2029 (USD MILLION)          263

TABLE 308         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         266

TABLE 309         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        266

TABLE 310         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   266

TABLE 311         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    267

TABLE 312         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    267

TABLE 313         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 267

TABLE 314         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 268

TABLE 315         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          268

TABLE 316         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 268

TABLE 317         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          269

TABLE 318         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          269

TABLE 319         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     269

TABLE 320         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY END USER, 2022–2029 (USD MILLION)            270

TABLE 321         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          271

TABLE 322         US: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)    271

TABLE 323         US: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    271

TABLE 324         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          272

TABLE 325         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS,

BY TYPE, 2022–2029 (USD MILLION)       272

TABLE 326         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES,

BY TYPE, 2022–2029 (USD MILLION)       272

TABLE 327         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 273

TABLE 328         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          273

TABLE 329         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     273

TABLE 330         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    274

TABLE 331         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          274

TABLE 332         US: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          275

TABLE 333         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          276

TABLE 334         CANADA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       276

TABLE 335         CANADA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    276

TABLE 336         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)    277

TABLE 337         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  277

TABLE 338         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   277

TABLE 339         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              278

TABLE 340         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       278

TABLE 341         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              278

TABLE 342         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              279

TABLE 343         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          279

TABLE 344         CANADA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          280

TABLE 345         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY,

2022–2029 (USD MILLION)          281

TABLE 346         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          281

TABLE 347         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       282

TABLE 348         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       282

TABLE 349         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          282

TABLE 350         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  283

TABLE 351         EUROPE HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   283

TABLE 352         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              283

TABLE 353         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       284

TABLE 354         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              284

TABLE 355         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              284

TABLE 356         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          285

TABLE 357         EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          285

TABLE 358         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          286

TABLE 359         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       286

TABLE 360         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       287

TABLE 361         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)    287

TABLE 362         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  287

TABLE 363         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   288

TABLE 364         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              288

TABLE 365         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       288

TABLE 366         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              289

TABLE 367         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              289

TABLE 368         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     289

TABLE 369         GERMANY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          290

TABLE 370         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          291

TABLE 371         UK: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       291

TABLE 372         UK: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       292

TABLE 373         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          292

TABLE 374         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS,

BY TYPE, 2022–2029 (USD MILLION)       292

TABLE 375         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES,

BY TYPE, 2022–2029 (USD MILLION)       293

TABLE 376         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 293

TABLE 377         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          293

TABLE 378         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     294

TABLE 379         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    294

TABLE 380         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          294

TABLE 381         UK: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          295

TABLE 382         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          296

TABLE 383         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       296

TABLE 384         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    296

TABLE 385         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          297

TABLE 386         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  297

TABLE 387         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   297

TABLE 388         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              298

TABLE 389         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       298

TABLE 390         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              298

TABLE 391         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              299

TABLE 392         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          299

TABLE 393         FRANCE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          300

TABLE 394         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          301

TABLE 395         ITALY: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   301

TABLE 396         ITALY: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    301

TABLE 397         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          302

TABLE 398         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)          302

TABLE 399         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES,

BY TYPE, 2022–2029 (USD MILLION)       302

TABLE 400         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 303

TABLE 401         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       303

TABLE 402         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     303

TABLE 403         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    304

TABLE 404         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          304

TABLE 405         ITALY: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          305

TABLE 406         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          306

TABLE 407         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   306

TABLE 408         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    306

TABLE 409         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          307

TABLE 410         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)          307

TABLE 411         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)            307

TABLE 412         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 308

TABLE 413         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       308

TABLE 414         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     308

TABLE 415         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    309

TABLE 416         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          309

TABLE 417         SPAIN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          310

TABLE 418         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        311

TABLE 419         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   311

TABLE 420         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    311

TABLE 421         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    312

TABLE 422         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 312

TABLE 423         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 312

TABLE 424         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          313

TABLE 425         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 313

TABLE 426         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          313

TABLE 427         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          314

TABLE 428         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     314

TABLE 429         REST OF EUROPE: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)         315

TABLE 430         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         318

TABLE 431         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        318

TABLE 432         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       318

TABLE 433         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)     319

TABLE 434         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 319

TABLE 435         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 319

TABLE 436         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 320

TABLE 437         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          320

TABLE 438         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 320

TABLE 439         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          321

TABLE 440         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          321

TABLE 441         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  321

TABLE 442         ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)         322

TABLE 443         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          323

TABLE 444         CHINA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       323

TABLE 445         CHINA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    324

TABLE 446         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          324

TABLE 447         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)          324

TABLE 448         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)            325

TABLE 449         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 325

TABLE 450         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          325

TABLE 451         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     326

TABLE 452         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    326

TABLE 453         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          326

TABLE 454         CHINA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          327

TABLE 455         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          328

TABLE 456         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   328

TABLE 457         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    329

TABLE 458         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          329

TABLE 459         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)          329

TABLE 460         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)            330

TABLE 461         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 330

TABLE 462         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          330

TABLE 463         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     331

TABLE 464         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    331

TABLE 465         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          331

TABLE 466         JAPAN: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          332

TABLE 467         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          333

TABLE 468         INDIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   333

TABLE 469         INDIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    334

TABLE 470         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)        334

TABLE 471         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)          334

TABLE 472         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)            335

TABLE 473         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 335

TABLE 474         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          335

TABLE 475         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     336

TABLE 476         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    336

TABLE 477         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          336

TABLE 478         INDIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          337

TABLE 479        AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          338

TABLE 480         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       338

TABLE 481         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       339

TABLE 482        AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)    339

TABLE 483         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  339

TABLE 484         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   340

TABLE 485         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              340

TABLE 486         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)     340

TABLE 487         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              341

TABLE 488         AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              341

TABLE 489        AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)     341

TABLE 490        AUSTRALIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          342

TABLE 491         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        343

TABLE 492         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   343

TABLE 493         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       343

TABLE 494         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 344

TABLE 495         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 344

TABLE 496         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 344

TABLE 497         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          345

TABLE 498         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 345

TABLE 499         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          345

TABLE 500         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          346

TABLE 501         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  346

TABLE 502         SOUTH KOREA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)         347

TABLE 503         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY OFFERING, 2022–2029 (USD MILLION)            347

TABLE 504         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)      348

TABLE 505         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       348

TABLE 506         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    348

TABLE 507         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)              349

TABLE 508         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   349

TABLE 509         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              349

TABLE 510         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)  350

TABLE 511         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              350

TABLE 512         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              350

TABLE 513         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     351

TABLE 514         REST OF ASIA PACIFIC: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY END USER, 2022–2029 (USD MILLION)            351

TABLE 515         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         352

TABLE 516         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        353

TABLE 517         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   353

TABLE 518         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    353

TABLE 519         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 354

TABLE 520         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 354

TABLE 521         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 354

TABLE 522         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          355

TABLE 523         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 355

TABLE 524         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          355

TABLE 525         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          356

TABLE 526         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  356

TABLE 527         LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)         357

TABLE 528         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)   358

TABLE 529         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   358

TABLE 530         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    358

TABLE 531         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          359

TABLE 532         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)          359

TABLE 533         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)            359

TABLE 534         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 360

TABLE 535         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       360

TABLE 536         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     360

TABLE 537         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    361

TABLE 538         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          361

TABLE 539         BRAZIL: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          362

TABLE 540         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          362

TABLE 541         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   363

TABLE 542         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    363

TABLE 543         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2022–2029 (USD MILLION)          363

TABLE 544         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  364

TABLE 545         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   364

TABLE 546         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              364

TABLE 547         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       365

TABLE 548         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              365

TABLE 549         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              365

TABLE 550         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          366

TABLE 551         MEXICO: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          366

TABLE 552         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY OFFERING, 2022–2029 (USD MILLION)            367

TABLE 553         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)      367

TABLE 554         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       367

TABLE 555         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    368

TABLE 556         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  368

TABLE 557         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   368

TABLE 558         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              369

TABLE 559         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 369

TABLE 560         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              369

TABLE 561         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              370

TABLE 562         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     370

TABLE 563         REST OF LATIN AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY END USER, 2022–2029 (USD MILLION)            371

TABLE 564         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         372

TABLE 565         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        372

TABLE 566         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       372

TABLE 567         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       373

TABLE 568         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 373

TABLE 569         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 373

TABLE 570         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 374

TABLE 571         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          374

TABLE 572         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 374

TABLE 573         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          375

TABLE 574         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          375

TABLE 575         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  375

TABLE 576         MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)         376

TABLE 577         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY COUNTRY, 2022–2029 (USD MILLION)         376

TABLE 578         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        377

TABLE 579         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   377

TABLE 580         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    377

TABLE 581         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    378

TABLE 582         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 378

TABLE 583         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 378

TABLE 584         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          379

TABLE 585         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 379

TABLE 586         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          379

TABLE 587         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          380

TABLE 588         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     380

TABLE 589         GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)         381

TABLE 590         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING, 2022–2029 (USD MILLION)        381

TABLE 591         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET,

BY TYPE, 2022–2029 (USD MILLION)       382

TABLE 592         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET,

BY TYPE, 2022–2029 (USD MILLION)       382

TABLE 593         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION) 382

TABLE 594         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION) 383

TABLE 595         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION) 383

TABLE 596         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          383

TABLE 597         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION) 384

TABLE 598         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)          384

TABLE 599         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)          384

TABLE 600         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION, 2022–2029 (USD MILLION)  385

TABLE 601         SAUDI ARABIA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER, 2022–2029 (USD MILLION)         385

TABLE 602         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY OFFERING, 2022–2029 (USD MILLION)          386

TABLE 603         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)      386

TABLE 604         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       387

TABLE 605         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    387

TABLE 606         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  387

TABLE 607         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   388

TABLE 608         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              388

TABLE 609         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)  388

TABLE 610         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              389

TABLE 611         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              389

TABLE 612         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     389

TABLE 613         UNITED ARAB EMIRATES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY END USER, 2022–2029 (USD MILLION)          390

TABLE 614         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY OFFERING, 2022–2029 (USD MILLION)            390

TABLE 615         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)      391

TABLE 616         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       391

TABLE 617         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    391

TABLE 618         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)  392

TABLE 619         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   392

TABLE 620         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 392

TABLE 621         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)  393

TABLE 622         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              393

TABLE 623         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              393

TABLE 624         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     394

TABLE 625         REST OF GCC COUNTRIES: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY END USER, 2022–2029 (USD MILLION)          394

TABLE 626         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY OFFERING, 2022–2029 (USD MILLION)            395

TABLE 627         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)      395

TABLE 628         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)       395

TABLE 629         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY TECHNOLOGY, 2022–2029 (USD MILLION)    396

TABLE 630         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)              396

TABLE 631         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)   396

TABLE 632         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              397

TABLE 633         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)  397

TABLE 634         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)              397

TABLE 635         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET

FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)              398

TABLE 636         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY APPLICATION, 2022–2029 (USD MILLION)     398

TABLE 637         REST OF MIDDLE EAST: HIGH-THROUGHPUT SCREENING (HTS) MARKET,

BY END USER, 2022–2029 (USD MILLION)            399

TABLE 638         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2022–2029 (USD MILLION)          400

TABLE 639         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)   400

TABLE 640         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)    400

TABLE 641         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY, 2022–2029 (USD MILLION)          401

TABLE 642         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR CELL-BASED ASSAYS, BY TYPE, 2022–2029 (USD MILLION)          401

TABLE 643         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR 3D CELL CULTURES, BY TYPE, 2022–2029 (USD MILLION)            401

TABLE 644         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-BASED TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION) 402

TABLE 645         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR HYDROGELS,

BY TYPE, 2022–2029 (USD MILLION)       402

TABLE 646         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR ANIMAL-DERIVED HYDROGELS, BY TYPE, 2022–2029 (USD MILLION)     402

TABLE 647         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET FOR SCAFFOLD-FREE TECHNOLOGY, BY TYPE, 2022–2029 (USD MILLION)    403

TABLE 648         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2022–2029 (USD MILLION)          403

TABLE 649         AFRICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2022–2029 (USD MILLION)          403

TABLE 650         OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN HIGH-THROUGHPUT SCREENING MARKET       405

TABLE 651         HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEGREE OF COMPETITION 408

TABLE 652         HIGH-THROUGHPUT SCREENING (HTS) MARKET: OFFERING FOOTPRINT      413

TABLE 653         HIGH-THROUGHPUT SCREENING (HTS) MARKET: APPLICATION FOOTPRINT       414

TABLE 654         HIGH-THROUGHPUT SCREENING (HTS) MARKET: REGION FOOTPRINT      415

TABLE 655         HIGH-THROUGHPUT SCREENING (HTS) MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS   418

TABLE 656         HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS              419

TABLE 657         HIGH-THROUGHPUT SCREENING (HTS) MARKET: PRODUCT LAUNCHES,

JANUARY 2021–MAY 2024            422

TABLE 658         HIGH-THROUGHPUT SCREENING (HTS) MARKET: DEALS,

JANUARY 2021–MAY 2024            424

TABLE 659         HIGH-THROUGHPUT SCREENING (HTS) MARKET: EXPANSIONS,

JANUARY 2021–MAY 2024          426

TABLE 660         THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW              427

TABLE 661         THERMO FISHER SCIENTIFIC INC.: PRODUCTS & SERVICES OFFERED          428

TABLE 662         THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS      432

TABLE 663         THERMO FISHER SCIENTIFIC INC.: DEALS          432

TABLE 664         THERMO FISHER SCIENTIFIC INC.: EXPANSIONS            433

TABLE 665         AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 435

TABLE 666         AGILENT TECHNOLOGIES, INC.: PRODUCTS & SERVICES OFFERED          436

TABLE 667         AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & UPGRADES       440

TABLE 668         AGILENT TECHNOLOGIES, INC.: DEALS             441

TABLE 669         MERCK KGAA: BUSINESS OVERVIEW     443

TABLE 670         MERCK KGAA: PRODUCTS & SERVICES OFFERED           444

TABLE 671         MERCK KGAA: OTHER DEVELOPMENTS             446

TABLE 672         DANAHER CORPORATION: BUSINESS OVERVIEW           447

TABLE 673         DANAHER CORPORATION: PRODUCTS & SERVICES OFFERED              448

TABLE 674         DANAHER CORPORATION: PRODUCT & SERVICE LAUNCHES              452

TABLE 675         DANAHER CORPORATION: DEALS         453

TABLE 676         DANAHER CORPORATION: EXPANSIONS           454

TABLE 677         REVVITY, INC.: BUSINESS OVERVIEW    455

TABLE 678         REVVITY INC.: PRODUCTS & SERVICES OFFERED           456

TABLE 679         REVVITY, INC.: PRODUCT LAUNCHES   459

TABLE 680         REVVITY, INC.: DEALS  459

TABLE 681         TECAN GROUP LTD.: BUSINESS OVERVIEW       460

TABLE 682         TECAN GROUP LTD.: PRODUCTS & SERVICES OFFERED              461

TABLE 683         TECAN GROUP LTD.: PRODUCT LAUNCHES & UPGRADES              463

TABLE 684         TECAN GROUP LTD.: DEALS     463

TABLE 685         BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW   464

TABLE 686         BIO-RAD LABORATORIES, INC.: PRODUCTS & SERVICES OFFERED          465

TABLE 687         BIO-RAD LABORATORIES, INC.: PRODUCT LAUNCHES  468

TABLE 688         CORNING INCORPORATED: BUSINESS OVERVIEW         469

TABLE 689         CORNING INCORPORATED: PRODUCTS & SERVICES OFFERED              470

TABLE 690         CORNING INCORPORATED: PRODUCT LAUNCHES        472

TABLE 691         METTLER-TOLEDO INTERNATIONAL INC.: BUSINESS OVERVIEW        473

TABLE 692         METTLER-TOLEDO INTERNATIONAL INC.: PRODUCTS & SERVICES OFFERED      474

TABLE 693         METTLER-TOLEDO INTERNATIONAL INC.: PRODUCT LAUNCHES       476

TABLE 694         LONZA GROUP: BUSINESS OVERVIEW   477

TABLE 695         LONZA GROUP: PRODUCTS & SERVICES OFFERED         478

TABLE 696         LONZA GROUP: DEALS 479

TABLE 697         WATERS CORPORATION: BUSINESS OVERVIEW 480

TABLE 698         WATERS CORPORATION: PRODUCTS & SERVICES OFFERED              481

TABLE 699         WATERS CORPORATION: PRODUCT LAUNCHES            483

TABLE 700         WATERS CORPORATION: DEALS            484

TABLE 701         SARTORIUS AG: BUSINESS OVERVIEW   485

TABLE 702         SARTORIUS AG: PRODUCTS & SERVICES OFFERED         486

TABLE 703         SARTORIUS AG: PRODUCT LAUNCHES 491

TABLE 704         EPPENDORF SE: BUSINESS OVERVIEW  492

TABLE 705         EPPENDORF SE: PRODUCTS & SERVICES OFFERED        493

TABLE 706         EPPENDORF SE: DEALS 495

TABLE 707         EPPENDORF SE: EXPANSIONS   495

TABLE 708         PORVAIR PLC: BUSINESS OVERVIEW     496

TABLE 709         PORVAIR PLC: PRODUCTS & SERVICES OFFERED           497

TABLE 710         GREINER AG: BUSINESS OVERVIEW       499

TABLE 711         GREINER AG: PRODUCTS & SERVICES OFFERED             500

TABLE 712         CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: BUSINESS OVERVIEW    503

TABLE 713         CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:

PRODUCTS & SERVICES OFFERED         504

TABLE 714         CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: DEALS  505

TABLE 715         EUROFINS SCIENTIFIC: BUSINESS OVERVIEW    506

TABLE 716         EUROFINS SCIENTIFIC: PRODUCTS & SERVICES OFFERED              507

TABLE 717         EUROFINS SCIENTIFIC: SERVICE LAUNCHES     509

TABLE 718         EUROFINS SCIENTIFIC: DEALS  509

TABLE 719         EUROFINS SCIENTIFIC: EXPANSIONS    510

TABLE 720         HAMILTON COMPANY: BUSINESS OVERVIEW   511

TABLE 721         HAMILTON COMPANY: PRODUCTS & SERVICES OFFERED              511

TABLE 722         HAMILTON COMPANY: PRODUCT LAUNCHES  512

TABLE 723         HAMILTON COMPANY: DEALS 513

TABLE 724         AURORA BIOMED INC.: BUSINESS OVERVIEW   514

TABLE 725         AURORA BIOMED INC.: PRODUCTS & SERVICES OFFERED              514

TABLE 726         GILSON INCORPORATED: BUSINESS OVERVIEW             515

TABLE 727         GILSON INCORPORATED: PRODUCTS & SERVICES OFFERED              515

TABLE 728         GILSON INCORPORATED.: PRODUCT LAUNCHES          521

TABLE 729         GILSON INCORPORATED: DEALS           522

TABLE 730         BRAND GMBH + CO KG: BUSINESS OVERVIEW  523

TABLE 731         BRAND GMBH + CO KG: PRODUCTS & SERVICES OFFERED              524

TABLE 732         BRAND GMBH + CO KG: EXPANSIONS   527

LIST OF FIGURES

FIGURE 1           HIGH-THROUGHPUT SCREENING (HTS) MARKET SEGMENTATION           48

FIGURE 2           RESEARCH DESIGN       53

FIGURE 3           HIGH-THROUGHPUT SCREENING (HTS) MARKET: BREAKDOWN OF PRIMARIES     55

FIGURE 4           MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 2023              56

FIGURE 5           MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023             56

FIGURE 6           ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023  57

FIGURE 7           MARKET VALIDATION FROM PRIMARY EXPERTS           58

FIGURE 8           MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH       58

FIGURE 9           HIGH-THROUGHPUT SCREENING (HTS) MARKET: CAGR PROJECTIONS, 2024–2029           60

FIGURE 10         HIGH-THROUGHPUT SCREENING (HTS) MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES              60

FIGURE 11         DATA TRIANGULATION METHODOLOGY         61

FIGURE 12         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY OFFERING,

2024 VS. 2029 (USD MILLION)     64

FIGURE 13         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY TECHNOLOGY,

2024 VS. 2029 (USD MILLION)   65

FIGURE 14         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY APPLICATION,

2024 VS. 2029 (USD MILLION)     65

FIGURE 15         HIGH-THROUGHPUT SCREENING (HTS) MARKET, BY END USER,

2024 VS. 2029 (USD MILLION)     66

FIGURE 16         GEOGRAPHICAL SNAPSHOT: HIGH-THROUGHPUT SCREENING (HTS) MARKET      67

FIGURE 17         GROWING ADOPTION OF OPEN INNOVATIVE MODELS IN PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO DRIVE MARKET GROWTH          68

FIGURE 18         CONSUMABLES DOMINATED NORTH AMERICAN HIGH-THROUGHPUT SCREENING (HTS) MARKET IN 2023       69

FIGURE 19         CONSUMABLES TO CONTINUE TO DOMINATE MARKET BY 2029      70

FIGURE 20         PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2023     70

FIGURE 21         ASIA PACIFIC TO REGISTER HIGHEST GROWTH RATE IN HIGH-THROUGHPUT SCREENING (HTS) MARKET FROM 2024 TO 2029              71

FIGURE 22         HIGH-THROUGHPUT SCREENING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES       72

FIGURE 23         RISING GLOBAL PHARMACEUTICAL R&D SPENDING, 2014–2028      76

FIGURE 24         REVENUE SHIFT & NEW POCKETS FOR HIGH-THROUGHPUT SCREENING (HTS) SOLUTION PROVIDERS         86

FIGURE 25         PRICING TREND FOR INSTRUMENTS, 2021–2023             88

FIGURE 26         VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING PRODUCT DEVELOPMENT PHASE         89

FIGURE 27         DIRECT DISTRIBUTION—STRATEGY PREFERRED BY PROMINENT COMPANIES          90

FIGURE 28         ECOSYSTEM ANALYSIS: HIGH-THROUGHPUT SCREENING MARKET            91

FIGURE 29         TOP APPLICANTS & OWNERS (COMPANIES) FOR HIGH-THROUGHPUT

SCREENING PATENTS (JANUARY 2012–DECEMBER 2023)             95

FIGURE 30         HIGH-THROUGHPUT SCREENING MARKET: PORTER’S FIVE FORCES ANALYSIS         110

FIGURE 31         KEY BUYING CRITERIA FOR END USERS              114

FIGURE 32         NORTH AMERICA: HIGH-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT     265

FIGURE 33         ASIA PACIFIC: HIGHT-THROUGHPUT SCREENING (HTS) MARKET SNAPSHOT     317

FIGURE 34         REVENUE ANALYSIS OF KEY PLAYERS, 2021–2023 (USD MILLION)          407

FIGURE 35         MARKET SHARE ANALYSIS OF KEY PLAYERS, 2023          408

FIGURE 36         HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY

EVALUATION MATRIX (KEY PLAYERS), 2023      411

FIGURE 37         HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY FOOTPRINT      412

FIGURE 38         HIGH-THROUGHPUT SCREENING (HTS) MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 417

FIGURE 39         EV/EBITDA OF KEY VENDORS   420

FIGURE 40         YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS             420

FIGURE 41         HIGH-THROUGHPUT SCREENING (HTS) MARKET: BRAND/PRODUCT

COMPARATIVE ANALYSIS          421

FIGURE 42         THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)   428

FIGURE 43         AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2023)              436

FIGURE 44         MERCK KGAA: COMPANY SNAPSHOT (2023)      444

FIGURE 45         DANAHER CORPORATION: COMPANY SNAPSHOT (2023)              448

FIGURE 46         REVVITY, INC.: COMPANY SNAPSHOT (2023)     456

FIGURE 47         TECAN GROUP LTD. COMPANY SNAPSHOT (2023)         461

FIGURE 48         BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)              465

FIGURE 49         CORNING INCORPORATED: COMPANY SNAPSHOT (2023)              470

FIGURE 50         METTLER-TOLEDO INTERNATIONAL INC.: COMPANY SNAPSHOT (2023)          474

FIGURE 51         LONZA GROUP: COMPANY SNAPSHOT (2023)   478

FIGURE 52         WATERS CORPORATION: COMPANY SNAPSHOT (2023) 481

FIGURE 53         SARTORIUS AG: COMPANY SNAPSHOT (2023)   486

FIGURE 54         EPPENDORF SE: COMPANY SNAPSHOT (2023)   493

FIGURE 55         PORVAIR PLC: COMPANY SNAPSHOT (2023)      497

FIGURE 56         GREINER AG: COMPANY SNAPSHOT (2023)        500

FIGURE 57         CHARLES RIVER LABORATORIES INTERNATIONAL, INC.:

COMPANY SNAPSHOT (2023)    504

FIGURE 58         EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)    507

MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価判定を受けているインドに本社をおく市場調査会社です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • ご注文後2営業日以内

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

割引可能なレポートが多数ございます。価格・サンプルについてはお気軽にご相談ください。

最新調査レポート

• CAR-T細胞療法市場 – 2029年までの世界予測 2024-07-22
• ストーンフローリング市場 – 2029年までの世界予測 2024-07-19
• グリーンメタノール市場 – 2030年までの世界予測 2024-07-19
• テトラアセチルエチレンジアミン (TAED) 市場 – 2029年までの世界予測 2024-07-18
• バッテリーTIC（試験・検査・認証）市場 – 2029年までの世界予測 2024-07-18

MarketsandMarkets  出版レポート一覧